Biocon, Mylan launch Ogivri in Australia

Pharma |  News | 0 Comment | 02 Aug, 2019

Biocon Ltd. and Mylan N.V. have announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar to Herceptin®1 (trastuzumab), for the treatment of HER2-ove...Read more

FDA new drug approvals up 11% in 2018

Pharma |  Analysis | 0 Comment | 01 Aug, 2019

In 2018 the US Food and Drug Administration (FDA) accepted 137 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities (NMEs) and new formulatio...Read more

Indian’s big pharma companies finding new growth opportunities in China

Pharma |  Analysis | 0 Comment | 31 Jul, 2019

Indian pharmaceutical companies are finding lucrative opportunities for growth in the Chinese pharma market, which is set to rise from nearly US$132bn in 2018 to more than US$209bn by 2022,...Read more

Alterity Therapeutics announces successful completion of Phase 1 Clinical Trial

Pharma |  News | 0 Comment | 31 Jul, 2019

Alterity Therapeutics Limited has announced that it has successfully completed its Phase 1 study of PBT434, a novel, orally bioavailable small molecule inhibitor of alpha- synuclein aggrega...Read more

Alizé Pharma 3 raises $75M in Series A

Pharma |  News | 0 Comment | 31 Jul, 2019

Alizé Pharma 3, a company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases has completed a €67 million Series A financing round. The...Read more

Mezzion Pharma announces positive results from FUEL trial

Pharma |  News | 0 Comment | 31 Jul, 2019

Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fontan Udenafil Exercise Longitudinal (FUEL) trial, which was designed to ...Read more

Takeda, Pfizer terminate co-promotion of RA Drug Enbrel

Pharma |  News | 0 Comment | 31 Jul, 2019

Pfizer Japan Inc. and Takeda Pharmaceutical Company Limited have announced the termination of co-promotion for the rheumatoid arthritis/juvenile idiopathic arthritis treatment "Enbrel®"...Read more

Strides enters into JV with Sihuan Pharma

Pharma |  News | 0 Comment | 30 Jul, 2019

Indian firm Strides Pharma Science Limited has announced that its step down subsidiary Strides Pharma Global Pte, Singapore (SPG) has entered into a Joint Venture (JV) with Sun Moral Intern...Read more

Mylan and Pfizer to create a new company

Pharma |  News | 0 Comment | 30 Jul, 2019

Mylan and Pfizer Inc. have announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global...Read more

Sanofi provides update on Zynquista type 2 diabetes program

Pharma |  News | 0 Comment | 29 Jul, 2019

Sanofi has announced topline results from three Phase 3 trials of ZynquistaTM (sotagliflozin) in adults living with type 2 diabetes from the InSynchrony clinical program. Given the pri...Read more

Hikma and Richter sign pact to market cariprazine in MENA

Pharma |  News | 0 Comment | 29 Jul, 2019

Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, and Gedeon Richter PLC (Richter) have announced the signing of an exclusive license agreement to commercialise cariprazi...Read more

Aucta Pharma licenses Vigabatrin for Oral Solution in China

Pharma |  News | 0 Comment | 29 Jul, 2019

US headquartered Aucta Pharmaceuticals, Inc., a technology based company focusing on the development and commercialization of Branded Specialty Products, has announced that the Company has ...Read more

Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets

Pharma |  News | 0 Comment | 29 Jul, 2019

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC, a wholly-owned subsidiary of the leading India headquartered pharmaceutical company Cipla Limited, have announced that Alvotech and...Read more

GSK appoints Jonathan Symonds as non-executive chairman of Board

Pharma |  News | 0 Comment | 26 Jul, 2019

GlaxoSmithKline plc (GSK) has announced that Jonathan Symonds will succeed Sir Philip Hampton as Non-Executive Chairman of the GSK Board with effect from 1st September 2019. Jonathan is c...Read more

Astellas submits biologics license application for Urothelial Cancer drug

Pharma |  News | 0 Comment | 26 Jul, 2019

Japan based Astellas Pharma Inc. and US headquartered Seattle Genetics, Inc. have announced submission of a Biologics License Application for accelerated approval to the U.S. Food...Read more

Novartis, Mundipharma to enhance access of ophthalmology drugs

Pharma |  News | 0 Comment | 26 Jul, 2019

International healthcare organizations, Novartis and Mundipharma, have signed a landmark agreement for the marketing, sales and distribution rights of Novartis medicines in the general opht...Read more

Eli Lilly’s BAQSIMI nasal powder set to treat severe hypoglycemia

Pharma |  News | 0 Comment | 25 Jul, 2019

The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and abo...Read more

Cipla USA acquires worldwide rights for UTI drug

Pharma |  News | 0 Comment | 25 Jul, 2019

Cipla USA Inc., a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited, announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from A...Read more